Mauritius vs Yemen: Estimated antiretroviral therapy coverage among people living with HIV
Mauritius
36.0%
in 2025
Yemen
34.0%
in 2025
Mauritius rank
134th
Yemen rank
137th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Mauritius
- Yemen
How they compare
Mauritius currently reports 36.0% against 34.0% in Yemen, a difference of 2.0%.
That makes Mauritius's figure about 1.1 times Yemen's.
The two have swapped places 5 times across 26 shared years of data; in 2000 it was Yemen ahead.
Mauritius ranks 134th and Yemen ranks 137th of 143 countries.
Mauritius has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mauritius | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 1.1% | 1.8% | Mauritius |
| 2010s | 20.5% | 15.0% | 5.5% | Mauritius |
| 2020s | 30.7% | 28.7% | 2.0% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Mauritius or Yemen?
- Mauritius, at 36.0% against 34.0% in Yemen as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Mauritius and Yemen?
- 2.0%, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and Yemen?
- 26 years are reported by both, from 2000 to 2025.
- How do Mauritius and Yemen rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Mauritius ranks 134th and Yemen ranks 137th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.